Bal Pharma Limited has informed the Exchange regarding a press release dated November 15, 2021, titled "BAL PHARMA Ltd reports H1FY22 financial results with 290% growth in PAT, lead by strong performance of its API business.".
Press Release Nov 15 2021
Earlier from Bal Pharma
- Press Release Sep 28 2021
- Press Release Aug 10 2021
- Press Release Jul 01 2021
- Press Release May 24 2021